Hostname: page-component-6bf8c574d5-956mj Total loading time: 0 Render date: 2025-02-22T16:35:37.042Z Has data issue: false hasContentIssue false

Navigating the (Post-) Pandemic Landscape: An Analysis of COVID-19’s Current Status and Future Implications

Published online by Cambridge University Press:  21 February 2025

Filippo Bistagnino
Affiliation:
Department of Medical Biotechnology and Translational Medicine, International Medical School, Università degli Studi di Milano, Milan, Italy
Arunkumar Subramanian
Affiliation:
Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chennai, Tamil Nadu, India
Marcos Roberto Tovani-Palone*
Affiliation:
Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, India
*
Corresponding author: Marcos Roberto Tovani-Palone; Email: [email protected]

Abstract

Although it is true that the coronavirus disease 2019 (COVID-19) situation has improved significantly around the world, especially after the implementation of mass vaccination campaigns, there is still a lack of consensus both in the literature and among health authorities and other stakeholders about the current epidemiological situation. This, in turn, has been intensified after the World Health Organization declared the end of the public health emergency of international concern related to COVID-19. In this context, worrying questions have arisen, including a rampant dissemination of scientific misinformation coupled with increased resistance to the implementation and/or revocation of appropriate public health measures. In response to these challenges and hoping to contribute to their mitigation, this article addresses current aspects about the epidemiological situation of COVID-19, discusses long COVID and its controversies, the intensification of scientific misinformation as well as considerations on related health surveillance, and recommendations for improving the existing situation.

Type
Concepts in Disaster Medicine
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

World Health Organization (WHO). Statement on the Fifteenth Meeting of the IHR (2005) Emergency Committee on the COVID-19 Pandemic. Geneva: WHO; Published May 05, 2023. Accessed June 12, 2023. https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic?gclid=EAIaIQobChMIsanG5uy8_wIVbU9IAB10kw37EAAYASABEgLzDvD_BwEGoogle Scholar
Kupferschmidt, K, Wadman, M. End of COVID-19 emergencies sparks debate. Science. 2023;380(6645):566567. doi: 10.1126/science.adi6511. PMID: 37167400.CrossRefGoogle ScholarPubMed
Karafillakis, E, Van Damme, P, Hendrickx, G, et al. COVID-19 in Europe: New challenges for addressing vaccine hesitancy. Lancet. 2022;399(10326):699701. doi: 10.1016/S0140-6736(22)00150-7. PMID: 35123665; PMCID: PMC8813064.CrossRefGoogle ScholarPubMed
Tovani-Palone, MR. Scientific misinformation. Lancet. 2023;401(10392):19251926. doi: 10.1016/S0140-6736(23)00916-9. PMID: 37301577; PMCID: PMC10250007.CrossRefGoogle ScholarPubMed
World Health Organization (WHO). Emergencies: International health regulations and emergency committees. Geneva: WHO; Published December 19, 2019. Accessed June 12, 2023. https://www.who.int/news-room/questions-and-answers/item/emergencies-international-health-regulations-and-emergency-committeesGoogle Scholar
World Health Organization (WHO). Zero draft of the WHO CA+ for the consideration of the Intergovernmental Negotiating Body at its fourth meeting. Geneva: WHO; Published February 01, 2023. Accessed June 12, 2023. https://apps.who.int/gb/inb/pdf_files/inb4/A_INB4_3-en.pdfGoogle Scholar
World Health Organization (WHO). WHO coronavirus (COVID-19) dashboard. Geneva: WHO; 2024. Accessed November 14, 2024. https://covid19.who.int/Google Scholar
Thenon, N, Peyre, M, Huc, M, et al. COVID-19 in Africa: underreporting, demographic effect, chaotic dynamics, and mitigation strategy impact. PLoS Negl Trop Dis. 2022;16(9):e0010735. doi: 10.1371/journal.pntd.0010735. PMID: 36112718; PMCID: PMC9518880.CrossRefGoogle ScholarPubMed
Vandelli, V, Palandri, L, Coratza, P, et al. Conditioning factors in the spreading of Covid-19 - Does geography matter? Heliyon. 2024;10(3):e25810. doi: 10.1016/j.heliyon.2024.e25810. PMID: 38356610; PMCID: PMC10865316.CrossRefGoogle ScholarPubMed
Mogi, R, Spijker, J. The influence of social and economic ties to the spread of COVID-19 in Europe. J Popul Res (Canberra). 2022;39(4):495511. doi: 10.1007/s12546-021-09257-1. PMID: 33841047; PMCID: PMC8021302.CrossRefGoogle Scholar
Unnikrishnan, J, Mangalathu, S, Kutty, RV. Estimating under-reporting of COVID-19 cases in Indian states: an approach using a delay-adjusted case fatality ratio. BMJ Open. 2021;11(1):e042584. doi: 10.1136/bmjopen-2020-042584. PMID: 33472784; PMCID: PMC7818846.CrossRefGoogle ScholarPubMed
World Health Organization (WHO). Update on Omicron. Geneva: WHO; Published November 28, 2021. Accessed November 20, 2024. https://www.who.int/news/item/28-11-2021-update-on-omicronGoogle Scholar
Tovani-Palone, MR, Doshi, N, Pedersini, P. Inequity in the global distribution of monkeypox vaccines. World J Clin Cases. 2023;11(19):44984503. doi: 10.12998/wjcc.v11.i19.4498. PMID: 37469745; PMCID: PMC10353500.CrossRefGoogle ScholarPubMed
World Health Organization (WHO). Tracking SARS-CoV-2 Variants. Geneva: WHO; Published in 2023 with last update on January 24, 2025. Accessed June 20, 2023. https://www.who.int/activities/tracking-SARS-CoV-2-variantsGoogle Scholar
Centers for Disease Control and Prevention (CDC). SARS-CoV-2 Variant Classifications and Definitions. Atlanta: CDC; Published April 26, 2022. Accessed June 20, 2023. https://stacks.cdc.gov/view/cdc/116721Google Scholar
Jassat, W, Reyes, LF, Munblit, D, et al. Long COVID in low-income and middle-income countries: the hidden public health crisis. Lancet. 2023;402(10408):11151117. doi: 10.1016/S0140-6736(23)01685-9. PMID: 37652071CrossRefGoogle ScholarPubMed
Nikolich, , Rosen, CJ. Toward comprehensive care for long Covid. N Engl J Med. 2023;388(23):21132115. doi: 10.1056/NEJMp2304550. PMID: 37158440.CrossRefGoogle ScholarPubMed
Lineburg, KE, Smith, C. The Persistence of SARS-CoV-2 and its role in long Covid. NEJM Evid. 2023;2(9). doi: 10.1056/EVIDe2300165CrossRefGoogle ScholarPubMed
Warren-Gash, C, Lacey, A, Cook, S, et al. Post-COVID-19 condition and persisting symptoms in English schoolchildren: repeated surveys to March 2022. BMC Infect Dis. 2023;23(1):201. doi: 10.1186/s12879-023-08203-1. PMID: 37020190; PMCID: PMC10075149.CrossRefGoogle ScholarPubMed
Pazukhina, E, Andreeva, M, Spiridonova, E, et al. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID). BMC Med. 2022;20(1):244. doi: 10.1186/s12916-022-02448-4. PMID: 35794549; PMCID: PMC9257572.CrossRefGoogle ScholarPubMed
World Health Organization (WHO). A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021. Geneva: WHO; Published October 06, 2021. Accessed November 20, 2023. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1Google Scholar
Ely, EW, Brown, LM, Fineberg, HV, et al. Long Covid defined. N Engl J Med. 2024;391(18):17461753. doi: 10.1056/NEJMsb2408466. PMID: 39083764.CrossRefGoogle ScholarPubMed
Bistagnino, F, Pizzi, D, Mantovani, F, et al. Long COVID and gut candidiasis: what is the existing relationship? World J Gastroenterol. 2024;30(37):41044114. doi: 10.3748/wjg.v30.i37.4104. PMID: 39474404; PMCID: PMC11514539.CrossRefGoogle Scholar
Chakrovorty, SK, Hossain, KMA, Shafin, R, et al. Does post COVID-19 characterize new diseases and disabilities? Lancet Reg Health Southeast Asia. 2023;15:100234. doi: 10.1016/j.lansea.2023.100234. PMID: 37305608; PMCID: PMC10234345.CrossRefGoogle Scholar
Fernández-de-Las-Peñas, C, Palacios-Ceña, D, Gómez-Mayordomo, V, et al. Defining Post-COVID symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): an integrative classification. Int J Environ Res Public Health. 2021;18(5):2621. doi: 10.3390/ijerph18052621. PMID: 33807869; PMCID: PMC7967389.CrossRefGoogle ScholarPubMed
Alkodaymi, MS, Omrani, OA, Fawzy, NA, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657666. doi: 10.1016/j.cmi.2022.01.014. PMID: 35124265; PMCID: PMC8812092.CrossRefGoogle ScholarPubMed
Achaiah, NC, Subbarajasetty, SB, Shetty, RM. R0 and Re of COVID-19: can we predict when the pandemic outbreak will be contained? Indian J Crit Care Med. 2020;24(11):11251127. doi: 10.5005/jp-journals-10071-23649. PMID: 33384521; PMCID: PMC7751056.CrossRefGoogle Scholar
Liu, J, Xie, W, Wang, Y, et al. A comparative overview of COVID-19, MERS and SARS: review article. Int J Surg. 2020;81:18. doi: 10.1016/j.ijsu.2020.07.032. PMID: 32730205; PMCID: PMC7382925.CrossRefGoogle ScholarPubMed
Coburn, BJ, Wagner, BG, Blower, S. Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1). BMC Med. 2009;7:30. doi: 10.1186/1741-7015-7-30. PMID: 19545404; PMCID: PMC2715422.CrossRefGoogle ScholarPubMed
Alam, I, Radovanovic, A, Incitti, R, et al. CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants. Lancet Infect Dis. 2021;21(5):602. doi: 10.1016/S1473-3099(21)00078-5. Erratum in: Lancet Infect Dis. 2021. doi: 10.1016/S1473-3099(21)00139-0. PMID: 33571446; PMCID: PMC7906688.CrossRefGoogle Scholar
Zhou, B, Zhou, H, Zhang, X, et al. TEMPO: A transformer-based mutation prediction framework for SARS-CoV-2 evolution. Comput Biol Med. 2023;152:106264. doi: 10.1016/j.compbiomed.2022.106264. PMID: 36535209; PMCID: PMC9747230.CrossRefGoogle ScholarPubMed
Marcellusi, A, Fabiano, G, Sciattella, P, et al. The impact of COVID-19 vaccination on the Italian healthcare system: a scenario analysis. Clin Drug Investig. 2022;42(3):237242. doi: 10.1007/s40261-022-01127-9. PMID: 35218000; PMCID: PMC8881093.CrossRefGoogle ScholarPubMed
Supplementary material: File

Bistagnino et al. supplementary material

Bistagnino et al. supplementary material
Download Bistagnino et al. supplementary material(File)
File 90.4 KB